The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 14, 2014

Filed:

May. 12, 2012
Applicants:

James A. Cowan, Delaware, OH (US);

Ada S. Cowan, Delaware, OH (US);

Donna T. Palmer, San Diego, CA (US);

Inventors:

James A. Cowan, Delaware, OH (US);

Ada S. Cowan, Delaware, OH (US);

Donna T. Palmer, San Diego, CA (US);

Assignee:

MetalloPharm, LLC, Delaware, OH (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 19/00 (2006.01); C07K 7/08 (2006.01); C07K 14/46 (2006.01); C07K 2/00 (2006.01); A61K 38/05 (2006.01); A61K 38/10 (2006.01); A61K 38/17 (2006.01); A61K 38/08 (2006.01); A61P 31/00 (2006.01); C07K 5/068 (2006.01); C07K 1/113 (2006.01); A61K 47/48 (2006.01); C07K 7/06 (2006.01); C07K 5/02 (2006.01); C07H 23/00 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07H 23/00 (2013.01); C07K 2319/20 (2013.01); A61K 47/48076 (2013.01); C07K 7/06 (2013.01); C07K 5/022 (2013.01); A61K 38/00 (2013.01); C07K 2319/70 (2013.01);
Abstract

It is an object of the present invention to provide improved pharmacological properties to molecules which bind to a target with low affinity (hereinafter referred to as a 'ligand moiety') through linkage of such molecules to a metal binding moiety, thereby generating a combination molecule commonly referred to as a 'metallodrug' or “metallotherapeutic.” The metal binding domain of metallodrugs typically catalyzes oxido-reductase chemistry or acts as a Lewis-Acid catalyst, resulting in modification of proteins and nucleic acids that are in close proximity due to binding of the ligand moiety to its target.


Find Patent Forward Citations

Loading…